<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(9)</volume><submitter>Ferri G</submitter><pubmed_abstract>Glucagon-like peptide-1 receptor (GLP-1R) agonists are being used for the treatment of type 2 diabetes (T2D) and may have beneficial effects on the pancreatic β-cells. Here, we evaluated the effects of GLP-1R agonism on insulin secretory granule (ISG) dynamics in primary β-cells isolated from human islets exposed to palmitate-induced lipotoxic stress. Islets cells were exposed for 48 h to 0.5 mM palmitate (hereafter, 'Palm') with or without the addition of a GLP-1 agonist, namely 10 nM exendin-4 (hereafter, 'Ex-4'). Dissociated cells were first transfected with syncollin-EGFP in order to fluorescently mark the ISGs. Then, by applying a recently established spatiotemporal correlation spectroscopy technique, the average structural (i.e., size) and dynamic (i.e., the local diffusivity and mod</pubmed_abstract><journal>Pharmaceutics</journal><pagination>1403</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8464798</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells.</pubmed_title><pmcid>PMC8464798</pmcid><pubmed_authors>Grano F</pubmed_authors><pubmed_authors>Marselli L</pubmed_authors><pubmed_authors>De Luca C</pubmed_authors><pubmed_authors>Marchetti P</pubmed_authors><pubmed_authors>Pesce L</pubmed_authors><pubmed_authors>Cardarelli F</pubmed_authors><pubmed_authors>Ferri G</pubmed_authors><pubmed_authors>Tesi M</pubmed_authors><pubmed_authors>Occhipinti M</pubmed_authors><pubmed_authors>Suleiman M</pubmed_authors><pubmed_authors>Bugliani M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells.</name><description>Glucagon-like peptide-1 receptor (GLP-1R) agonists are being used for the treatment of type 2 diabetes (T2D) and may have beneficial effects on the pancreatic β-cells. Here, we evaluated the effects of GLP-1R agonism on insulin secretory granule (ISG) dynamics in primary β-cells isolated from human islets exposed to palmitate-induced lipotoxic stress. Islets cells were exposed for 48 h to 0.5 mM palmitate (hereafter, 'Palm') with or without the addition of a GLP-1 agonist, namely 10 nM exendin-4 (hereafter, 'Ex-4'). Dissociated cells were first transfected with syncollin-EGFP in order to fluorescently mark the ISGs. Then, by applying a recently established spatiotemporal correlation spectroscopy technique, the average structural (i.e., size) and dynamic (i.e., the local diffusivity and mod</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-20T02:04:37.127Z</modification><creation>2022-02-11T11:34:10.706Z</creation></dates><accession>S-EPMC8464798</accession><cross_references><pubmed>34575477</pubmed><doi>10.3390/pharmaceutics13091403</doi></cross_references></HashMap>